🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/11/2022 | 77,49 | 78,74 | 76,33 | 78,50 | +1,49% | 3,11% | 127.400 |
| 18/11/2022 | 80,68 | 80,80 | 77,08 | 77,35 | -1,28% | 4,61% | 170.000 |
| 17/11/2022 | 78,48 | 79,51 | 77,33 | 78,35 | -1,66% | 2,78% | 165.800 |
| 16/11/2022 | 79,51 | 81,22 | 77,29 | 79,67 | +0,77% | 4,94% | 120.600 |
| 15/11/2022 | 81,27 | 83,14 | 78,82 | 79,06 | -0,96% | 5,32% | 183.900 |
| 14/11/2022 | 81,41 | 83,95 | 79,66 | 79,83 | -1,95% | 5,27% | 162.700 |
| 11/11/2022 | 81,27 | 82,31 | 79,00 | 81,42 | -0,76% | 4,07% | 153.500 |
| 10/11/2022 | 77,77 | 83,45 | 77,77 | 82,04 | +9,02% | 7,30% | 251.900 |
| 09/11/2022 | 69,60 | 76,60 | 68,87 | 75,25 | +7,58% | 11,11% | 205.100 |
| 08/11/2022 | 67,80 | 73,88 | 65,33 | 69,95 | +11,31% | 12,61% | 305.300 |
| 07/11/2022 | 62,46 | 63,83 | 60,92 | 62,84 | +1,35% | 4,66% | 161.400 |
| 04/11/2022 | 63,46 | 63,47 | 60,12 | 62,00 | -1,29% | 5,28% | 195.900 |
| 03/11/2022 | 66,90 | 70,25 | 61,12 | 62,81 | -7,63% | 13,65% | 298.200 |
| 02/11/2022 | 59,91 | 68,84 | 57,77 | 68,00 | +28,83% | 18,48% | 641.200 |
| 01/11/2022 | 54,68 | 55,50 | 52,61 | 52,78 | -3,47% | 5,29% | 324.447 |
| 31/10/2022 | 55,06 | 55,83 | 54,27 | 54,68 | -0,47% | 2,84% | 180.017 |
| 28/10/2022 | 53,71 | 55,53 | 53,30 | 54,93 | +2,48% | 4,15% | 334.226 |
| 27/10/2022 | 55,02 | 55,27 | 53,34 | 53,61 | -1,23% | 3,52% | 204.863 |
| 26/10/2022 | 54,72 | 55,88 | 53,27 | 54,27 | -0,33% | 4,78% | 240.450 |
| 25/10/2022 | 54,60 | 55,68 | 54,39 | 54,45 | +0,58% | 2,38% | 280.525 |
| 24/10/2022 | 54,19 | 54,59 | 52,87 | 54,14 | -0,20% | 3,18% | 281.647 |
| 21/10/2022 | 54,07 | 54,80 | 53,00 | 54,25 | +1,35% | 3,32% | 241.091 |
| 20/10/2022 | 55,92 | 56,39 | 53,47 | 53,52 | -4,22% | 5,22% | 173.765 |
| 19/10/2022 | 57,16 | 57,16 | 55,52 | 55,88 | -3,69% | 2,87% | 192.520 |
| 18/10/2022 | 59,79 | 60,46 | 57,60 | 58,02 | -1,46% | 4,77% | 166.391 |
| 17/10/2022 | 56,76 | 59,38 | 56,44 | 58,88 | +5,48% | 5,18% | 186.269 |
| 14/10/2022 | 58,88 | 59,11 | 55,62 | 55,83 | -3,76% | 5,93% | 141.545 |
| 13/10/2022 | 55,96 | 58,31 | 55,09 | 58,01 | +1,91% | 5,75% | 113.653 |
| 12/10/2022 | 57,73 | 58,19 | 56,84 | 56,92 | -1,57% | 2,34% | 107.080 |
| 11/10/2022 | 57,65 | 58,87 | 56,28 | 57,84 | +0,27% | 4,49% | 167.353 |